PULM (Pulmatrix, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by PULM officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-01-30 | Michael J Higgins | Director | A | — | — |
| 2023-01-30 | Richard P. Batycky | Director | A | — | — |
| 2023-01-30 | Margaret Wasilewski | Chief Medical Officer | A | — | — |
| 2023-01-30 | Todd Bazemore | Director | A | — | — |
| 2023-01-30 | Michelle Siegert | Vice President, Finance | A | — | — |
| 2023-01-30 | Christopher Cabell | Director | A | — | — |
| 2023-01-30 | Teofilo David Raad | Chief Executive Officer | A | — | — |
| 2023-01-30 | Anand Varadan | Director | A | — | — |
| 2022-03-03 | Margaret Wasilewski | Chief Medical Officer | A | — | — |
| 2022-01-31 | Richard P. Batycky | Director | A | — | — |
| 2022-01-31 | Michael J Higgins | Director | A | — | — |
| 2022-01-31 | Christopher Cabell | Director | A | — | — |
| 2022-01-28 | Todd Bazemore | Director | A | — | — |
| 2022-01-28 | Michelle Siegert | Vice President, Finance | A | — | — |
| 2022-01-28 | Teofilo David Raad | Chief Executive Officer | A | — | — |
| 2022-01-28 | Anand Varadan | Director | A | — | — |
| 2021-07-28 | Anand Varadan | Director | A | — | — |
| 2021-02-01 | Amit Munshi | Director | A | — | — |
| 2021-02-01 | Christopher Cabell | Director | A | — | — |
| 2021-02-01 | Teofilo David Raad | Chief Executive Officer | A | — | — |
| 2021-02-01 | Michael J Higgins | Director | A | — | — |
| 2021-02-01 | Mark T Iwicki | Director | A | — | — |
| 2021-02-01 | Todd Bazemore | Director | A | — | — |
| 2021-02-01 | Richard P. Batycky | Director | A | — | — |
| 2021-02-01 | Michelle Siegert | Vice President, Finance | A | — | — |
| 2020-10-02 | Todd Bazemore | Director | A | — | — |
| 2020-09-01 | STEVEN GILLIS | Director | MIXED | — | — |
| 2020-06-25 | Christopher Cabell | Director | A | — | — |
| 2020-04-23 | Michael J Higgins | Director | A | — | — |
| 2020-04-23 | Michael J Higgins | Director | A | — | — |
| 2020-04-06 | Richard P. Batycky | Director | A | — | — |
| 2020-04-06 | Michael J Higgins | Director | A | — | — |
| 2020-04-06 | STEVEN GILLIS | Director | A | — | — |
| 2020-04-06 | Mark T Iwicki | Director | A | — | — |
| 2020-04-03 | Amit Munshi | Director | A | — | — |
| 2020-04-03 | Teofilo David Raad | Chief Executive Officer | A | — | — |
| 2020-01-13 | STEVEN GILLIS | Director | A | — | — |
| 2020-01-13 | Michael J Higgins | Director | A | — | — |
| 2020-01-13 | Amit Munshi | Director | A | — | — |
| 2020-01-13 | Teofilo David Raad | Chief Executive Officer | A | — | — |
| 2020-01-13 | Michelle Siegert | Vice President of Finance | A | — | — |
| 2020-01-13 | Richard P. Batycky | Director | A | — | — |
| 2020-01-13 | Mark T Iwicki | Director | A | — | — |
| 2019-05-20 | Michael J Higgins | Director | A | — | — |
| 2019-05-20 | Teofilo David Raad | Chief Executive Officer | A | — | — |
| 2019-05-20 | Amit Munshi | Director | A | — | — |
| 2019-05-20 | STEVEN GILLIS | Director | A | — | — |
| 2019-05-20 | William E. Duke | Chief Financial Officer | A | — | — |
| 2019-05-20 | Mark T Iwicki | Director | A | — | — |
| 2019-05-20 | Matthew L Sherman | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | — | 17,182 | — |
| — | 10%+ Owner | 13,491 | — |
| — | 10%+ Owner | 11,069 | — |
| — | Director | 1,535 | — |
| — | Director | 1,091 | — |
| — | Director | 844 | — |
| — | 10%+ Owner | 173 | — |
| — | 10%+ Owner | 131 | — |
| — | Director | 100 | — |
| — | Chief Executive Officer | 23 | — |
| — | Chief Scientific Officer | 11 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the PULM quote page; the site-wide leaderboard is on the insider transactions hub.